Catalogue navigation guide
Comparing Human and Animal ELISA Catalogue Pathways
Species is an important starting point when browsing ELISA products, but it is not a substitute for reviewing the complete product record. This guide compares human and animal catalogue routes, then shows how to verify the target, species, documentation, and intended research context before moving from a category page to an individual record.
Species as a catalogue field Human route Animal route Cross-species verification Moving to product recordsSpecies is a catalogue field, not a conclusion
When a researcher begins with a biological question, the catalogue often presents several possible routes: a human ELISA category, an animal category, a biomarker category, or a target-specific search. These routes organize records for discovery. They do not, by themselves, establish that two products are interchangeable, that a reagent recognizes the same form of an analyte in another species, or that a protocol validated in one context transfers to another.
The most useful first distinction is between catalogue routing and assay suitability. Catalogue routing answers: “Where should I begin looking?” Assay suitability requires a separate review of the exact product record and the planned experiment. That review may include the stated species, target name, assay format, supplied documentation, sample matrix, expected concentration range, controls, and any laboratory validation work required for the project.
Species labels are therefore best treated as high-value search metadata. They narrow the record set and reduce the chance of overlooking a species-specific listing. They are not evidence that a similarly named target behaves identically across species. Even when two records use the same target terminology, the records may represent different catalogue entries, different stated species, or different documentation. A careful comparison begins by preserving those distinctions rather than collapsing them into a single search result.
Working rule: use species to choose a browsing route; use the individual product record and supporting documentation to decide whether a candidate belongs on a research shortlist.Two catalogue pathways, one verification discipline
The human and animal routes answer different organizational needs. Both should end with the same record-level checks.
| Browse from | Useful first question | What the route can organize | What still requires verification |
|---|---|---|---|
| Human ELISA category | Is the planned research centered on a human-labelled target or human sample context? | Records grouped for human-focused discovery, including target or marker-oriented subcategories where available. | The exact product record, stated species, target identity, documentation, and fit with the planned sample and workflow. |
| Animal ELISA category | Is the project centered on an animal species or an animal-labelled target record? | Records organized around animal-focused discovery, with species or animal grouping used to narrow browsing. | The exact animal species, target wording, record-level documentation, and any additional work needed before comparison or use. |
| Target or biomarker category | Is the analyte or research marker the strongest starting point? | Records connected by target or biomarker terminology across relevant catalogue groupings. | Whether the species and other record fields match the experiment; target naming alone is insufficient. |
| Products search | Do I need to compare exact records after defining the basic criteria? | Searchable product discovery and direct access to individual product pages. | The researcher’s own inclusion criteria, documentation review, and validation plan. |
Starting from the human ELISA route
The human ELISA category is a practical starting point when human is the relevant catalogue species or when the initial search is framed around human-focused research. It provides a way to move from a broad record set toward more specific target, marker, or immunoglobulin groupings. The category is a navigation aid: it helps define the first boundary of the search without making a scientific claim about any particular kit.
At this stage, write down the fields that must remain fixed as the shortlist develops. A useful minimum is:
- Analyte identity: record the target as it appears in the product record, rather than relying only on an abbreviation or a familiar synonym.
- Species: distinguish a human-labelled record from an animal-labelled record and do not infer equivalence from target wording.
- Documentation: identify which product information is available for review before ordering or planning the experiment.
- Sample context: note the intended sample type and any matrix-related questions that may require separate investigation.
- Shortlist logic: record why a product remains under consideration and which unresolved questions would remove it.
For example, the catalogue includes a Human CRP ELISA Kit, identified in the supplied product record with catalogue number E-80CRP, application ELISA, and target CRP. It also includes a Human Hemopexin ELISA Kit, identified with catalogue number E-80HX, application ELISA, and target Hemopexin. These records illustrate how a human route can lead to distinct target records; they do not establish that either product is suitable for every human sample or experimental design.
A human category can also be useful when the target is known but the most appropriate subcategory is not. In that situation, the researcher can use the broader route to locate related target groupings, then return to the exact record. The transition matters: category browsing is broad by design, while experimental planning depends on record-level details and the researcher’s own inclusion criteria.
Human-route note
Keep the category path and product path separate in your notes. The first describes how you found a record; the second identifies what must be reviewed.
Starting from the animal ELISA route
The animal ELISA category is the corresponding starting point when the project is organized around an animal species or an animal-labelled product record. Animal browsing may then be narrowed through the relevant species grouping. The practical benefit is not a presumption of biological similarity; it is a clearer way to keep species-specific records visible during discovery.
Animal records should be read with the same discipline as human records, while preserving the animal species as an explicit field. Do not replace “animal” with a more specific species in your notes unless the individual record supports that wording. A broad animal category and a species-specific record are not equivalent levels of information.
Choose the broad route
Begin with animal-focused browsing when species is central to the research question.
Narrow by species
Use the available species grouping or search terms, keeping the exact species visible in the working record.
Confirm the target wording
Compare the target field, not only the product title or a familiar abbreviation.
Open the product record
Review the exact catalogue number and the documentation available for the candidate.
Two supplied records demonstrate why animal browsing should retain species as a separate comparison field. The Dog NGAL ELISA Kit is listed as catalogue number E-40NGL, with application ELISA and target NGAL (Lipocalin-2). The Rat NGAL ELISA Kit is listed as catalogue number E-25NGL, with the same stated application and target wording but a different species and a different catalogue number. The records therefore belong to a useful comparison set for catalogue navigation, not evidence that one record can replace the other.
When an animal project includes more than one species, avoid creating a single undifferentiated “animal” shortlist. Retain one row per exact record and capture the species, target wording, catalogue number, source URL, and unresolved documentation questions. This makes later review auditable and helps prevent a product found through a broad route from being mistaken for a species-matched candidate.
Animal-route note
“Animal” is a browsing family. “Dog” and “rat” are record-level distinctions in the supplied examples. Preserve the more specific field whenever it is available.
Why similarly named targets do not prove cross-species suitability
Cross-species comparison often begins with a shared target name. That is a reasonable way to find related records, but it is not sufficient evidence for interchangeability. A target label can identify a topic of interest while leaving important questions unresolved: which species is stated for the record, how the target is described, what documentation is supplied, what sample context is contemplated, and what validation work the laboratory may need to perform.
The supplied Dog NGAL and Rat NGAL records make this distinction concrete. Both records identify the target as NGAL (Lipocalin-2) and the application as ELISA. Their names are therefore related for catalogue navigation. They remain separate records, with different catalogue numbers—E-40NGL and E-25NGL—and different species labels. The shared target wording supports a related-record comparison; it does not, by itself, support a conclusion that the products are biologically equivalent, interchangeable, or appropriate for the same samples.
The same principle applies when moving in the other direction, from an animal record to a human record. A human product and an animal product may concern a related marker, but the record should be evaluated on its own terms. If the intended experiment is cross-species, the comparison should be explicit and documented rather than inferred from a search result.
Record-level evidence map
A useful cross-species review therefore has two layers. The first is a catalogue comparison: exact names, catalogue numbers, stated species, targets, applications, and links. The second is a scientific and operational review conducted against the planned study: analyte identity, sample matrix, controls, calibration approach, repeatability expectations, and documentation. The catalogue can support the first layer and help organize the second; it cannot replace the researcher’s validation decisions.
For broader background on turning a product search into a documented selection process, see the ELISA assay selection guide. That resource is a companion to catalogue navigation, not a substitute for reviewing the exact record.
A practical comparison sheet
Before deciding that a human and animal route have produced comparable candidates, create a small comparison sheet. The goal is not to force unlike records into one ranking. It is to make differences and unknowns visible.
Identity
Copy the exact product name, catalogue number, target field, and stated species. Keep source wording intact before adding internal notes.
Route
Record whether the product was found through a human category, animal category, biomarker route, or direct product search.
Documentation
List the supplied information that has been reviewed and mark missing or unresolved fields rather than filling them with assumptions.
Study fit
Compare the record against the planned analyte, species, sample context, controls, and reporting needs. This is a project decision, not a category label.
Cross-species status
Use a neutral status such as “related record,” “species differs,” or “requires further verification.” Avoid calling products interchangeable without evidence.
Next action
Specify whether to open the full record, request documentation, consult the laboratory team, or remove the candidate from the shortlist.
Move from category discovery to exact product records
Once the route is clear, move to the exact record rather than continuing to compare category labels. The supplied examples provide four distinct catalogue entries: two human records and two animal records. They can be used to practice a consistent record-review method.
Human CRP ELISA Kit
Target: CRP · Catalogue number: E-80CRP
Open product record → HumanHuman Hemopexin ELISA Kit
Target: Hemopexin · Catalogue number: E-80HX
Open product record → Animal / dogDog NGAL ELISA Kit
Target: NGAL (Lipocalin-2) · Catalogue number: E-40NGL
Open product record → Animal / ratRat NGAL ELISA Kit
Target: NGAL (Lipocalin-2) · Catalogue number: E-25NGL
Open product record →These records should be treated as examples of catalogue navigation. The human records illustrate distinct target entries within the human route. The dog and rat records illustrate why a shared target label should be accompanied by an explicit species and catalogue number. None of these examples, as presented here, is a recommendation for a particular study design or a conclusion about assay interchangeability.
Researchers who have already defined their basic criteria can return to the searchable Products page to continue discovery. Search is most useful when paired with a written record of the required species, target, documentation, and study context. That combination keeps browsing efficient without allowing a convenient keyword match to become an unsupported scientific conclusion.
Keep the pathway and the evidence separate
A human or animal category is a route into the catalogue. A product page is an exact record. A research decision requires the record, the available documentation, and the context of the planned experiment. Keeping those three levels separate makes cross-species comparisons more transparent and makes the next catalogue action easier to justify.